TBX3

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Seed Therapeutics
Seed TherapeuticsNY - New York
1 program
The Role of TBX3 in Human ES Cell DifferentiationN/A1 trial
Active Trials
NCT00581152WithdrawnEst. Aug 2010

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Seed TherapeuticsThe Role of TBX3 in Human ES Cell Differentiation

Clinical Trials (1)

NCT00581152Seed TherapeuticsThe Role of TBX3 in Human ES Cell Differentiation

The Role of TBX3 in Human ES Cell Differentiation

Start: Aug 2007Est. completion: Aug 2010
N/AWithdrawn

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space